R. A. Stockley (Birmingham, United Kingdom), Y. Fukuchi (Tokyo, Japan)
Upregulation of the inducible form of the nitric oxide synthase and nitrotyrosine formation in skeletal muscle of COPD patients with cachexia P. G. Gari, X. Busquets, M. Morla, J. Sauleda, A. G. N. Agusti (Palma de Mallorca, Spain)
| |
Edu-Care®, a randomised, multicentre study on education and quality of life in patients with chronic obstructive pulmonary disease (COPD) M. Carone, G. Bertolotti, I. Cerveri, F. De Benedetto, V. Fogliani, S. Nardini, L. Portalone, A. Rossi, C. M. Sanguinetti, M. Schiavina, C. F. Donner, the EduCare Group (Veruno, Italy)
| |
The effect of nutritional supplementation on body weight and composition in COPD patients participating in rehabilitation M. C. Steiner, R. L. Barton, S. J. Singh, M. D. L. Morgan (Leicester, United Kingdom)
| |
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice T. Schermer, N. Chavannes, A. Hendriks, R. Dekhuijzen, M. Wouters, H. van den Hoogen, O. van Schayck, C. Van Weel (Nijmegen, Maastricht, The Netherlands)
| |
The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD T. M. Wilkinson, I. S. Patel, M. Wilks, J. A. Wedzicha (London, United Kingdom)
| |
Systemic inflammatory response associated with injury of the respiratory muscles in healthy subjects and COPD patients C. Coronell, M. Orozco-Levi, A. Ramirez-Sarmiento, J. Martinez-Llorens, J. M. Broquetas, J. Gea (Barcelona, Spain)
| |
Reticular basement membrane (RBM) thickness, neutrophils and eosinophils in severe exacerbations of COPD and asthma Y. Qiu, J. Zhu, V. Bandi, A. E. Fraire, K. K. Guntupalli, P. K. Jeffery (London, United Kingdom; Houston, Worchester, United States Of America)
| |
Cytochrome P450 1A1 polymorphism and severity of COPD I. A. Yang, A. G. Dent, R. E. Slaughter, A. M. Tunnicliffe, G. C. Rabnott, J. G. Shaw, P. V. Zimmerman, K. M. Fong (Brisbane, Australia)
| |